Umar Butt
urabut@utu.fi +358 29 450 3790 +358 50 576 3939 |
- Ovarian Cancers with Low CIP2A Tumor Expression Constitute an APR-246-Sensitive Disease Subtype (2022)
- Molecular Cancer Therapeutics
- SHARPIN S146 phosphorylation mediates ARP2/3 interaction, cancer cell invasion and metastasis (2022)
- Journal of Cell Science
- CIP2A interacts with TopBP1 and drives basal-like breast cancer tumorigenesis (2021)
- Cancer Research
- Protein interactome of the Cancerous Inhibitor of Protein Phosphatase 2A (CIP2A) in Th17 cells (2020)
- Current Research in Immunology
- The Sharpin interactome reveals a role for Sharpin in lamellipodium formation via the Arp2/3 complex (2017)
- Journal of Cell Science
- Phosphorylation of Sharpin acts as a molecular switch to control Linear Ubiquitination Assembly Complex (LUBAC) and Arp2/3 function (2016)
- Molecular Biology of the Cell
UTU Research Portal